Search anything
Welcome to Multibagg AI
Log in to access personalized features
Welcome to Multibagg AI
Log in to access personalized features
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Latest stock market news, company updates, and price movements. Stay updated with market trends, earnings insights, and investment analysis.
Social media is tracking INR weakness as oil shocks, FPI outflows, and export tariffs squeeze dollar inflows, raising inflation and current account deficit concerns in 2026.
RBI’s board approved a record ₹2.87 trillion surplus transfer for FY26, aided by higher income and a larger balance sheet, alongside a lower contingency risk buffer.
Bata India reported a sharp Q4 FY25 profit decline while recommending a ₹9 final dividend with August 1, 2025 as record date, taking FY25 dividend to ₹19 per share.
IND Renewable Energy Ltd has increased authorised capital from ₹19 crore to ₹55 crore and approved fundraising of up to ₹100 crore via a preferential issue.
Vodafone Idea shares hit near 52-week highs after a one-time AGR gain drove March-quarter profit, while analysts flag fundraising and competition risks.
Gujarat Themis Biosyn will acquire 100% of Japan’s MicroBiopharm for about ₹1,300 crore via a Japan SPV, with closing targeted for Q2 FY27 after approvals.
US and Iran say a memorandum is largely negotiated to extend the April 8 ceasefire by 60 days and reopen the Strait of Hormuz in phases.
Brokerages recalibrated LTIMindtree price targets after March-quarter results, with cuts from Citi and Jefferies, selective upgrades, and a wide target range versus recent trading levels.
Colgate-Palmolive (India) slipped to around ₹2,157 on May 22, 2026, while broker views stayed cautious amid expensive valuation and multiple Sell/Reduce calls.
Reliance Infrastructure reported a 79% year-on-year drop in Q4 FY26 profit to ₹918 crore as expenses rose, while the board cleared a ₹3,000-crore fundraising plan.
RBI Governor Sanjay Malhotra said recent forex curbs are temporary steps to curb undue speculation, with intervention focused on smoothing volatility and not targeting a rupee level.
RBI Governor Sanjay Malhotra said the central bank is watching whether the West Asia supply shock entrenches inflation, ahead of the June 3-5, 2026 MPC meeting.
The Centre will assess inflation risks and monsoon progress by 15 June as IMD projects below-normal rainfall, while crude-led fuel pressures keep policymakers and the RBI cautious.
Le Travenues Technology (ixigo) reported higher FY26 and Q4FY26 profitability, with GTV at ₹18,692.7 crore, revenue growth of 34% and record quarterly PAT of ₹32.1 crore.
Aurobindo Pharma said the USFDA classified Eugia’s Unit-I inspection as OAI after four observations, while the company maintained there is no financial or operational impact.
Anupam Rasayan India will acquire 43.3% of Bliss GVS Pharma for ₹1,369.51 crore at ₹299 per share and make a mandatory open offer for another 26%.
